Penn-led consortium to advance imaging of brain diseases

A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of diseases like Parkinson’s by testing radiotracers they identified that illuminate α-synuclein (αSyn) or 4R tau proteins on positron emission tomography (PET) scans.

A ‘sense of urgency’ swirls in the UK pharma regulatory landscape – Pharmaceutical Technology

Share this article Credit: The last year saw plenty of updates from various regulatory agencies affecting the healthcare sector in the United Kingdom (UK). Credit:

January 23, 2024

A ‘Few Bad Apple’ Docs Spread COVID Misinformation on Social Media

Physician propagation of COVID-19 misinformation on social media — primarily discouraging people from getting the COVID vaccine — was limited but still potentially harmful, a

August 16, 2023

Biotech Stocks Well-PositionedFor The Fourth Quarter • Prudent Biotech

Biotechs are relatively better positioned in this fourth quarter compared to the broader market. The path of interest rates is clearer for 2022 and the

October 11, 2022

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.